Remnant Cholesterol as a Predictor of Target-Vessel Failure in Patients With In-Stent Restenosis

残余胆固醇作为支架内再狭窄患者靶血管失败的预测因子

阅读:1

Abstract

BACKGROUND: The clinical value of remnant cholesterol (RC) in patients with in-stent restenosis (ISR) who undergo percutaneous coronary intervention (PCI) is unknown. Therefore, this study aimed to clarify the association between increased RC levels and clinical prognosis in patients with ISR. METHODS: This retrospective study enrolled 836 patients diagnosed with ISR. The study population was divided into four quartiles (Q1-Q4) according to median RC levels. Using a multivariate Cox proportional hazards model and Kaplan-Meier (KM) curve, the association between RC levels and the study endpoint, defined as target-vessel failure (TVF) within 3 years after PCI, was investigated. A discordance analysis was also performed with several definitions. RESULTS: The KM curve showed an increased risk of TVF with elevated RC levels (p < 0.001). After adjustment, the RC level was identified as an independent predictor of TVF, regardless of whether the metric was considered as a continuous or categorical variable (hazard ratio (HR) = 1.37, 95% confidence interval (CI): 1.16-1.62; p < 0.001; HR = 3.43, 95% CI: 1.85-6.36; p < 0.001). Subgroup analysis showed that the RC-related TVF risk was more pronounced in patients with low-density lipoprotein cholesterol (LDL-C) <1.8 mmol/L (2.75 for each one standard deviation (SD) increase, 95% CI: 1.66-4.55; p for interaction < 0.001). In the discordance analysis, individuals with discordantly high RC levels rather than high LDL-C levels had an increased risk of TVF (HR = 2.02, 95% CI: 1.33-3.07; p < 0.001). CONCLUSIONS: An increased RC level was associated with an elevated risk of TVF in patients with ISR who underwent PCI. Further, the RC-related risk was more pronounced in patients with LDL-C levels <1.8 mmol/L.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。